City Therapeutics Inc. logo

City Therapeutics Inc.

CTY | NASDAQ
Chart Builder DCF Calculator
$20.84
+$0.13 (+0.63%)
Nov 2, 2026, 3:42 PM ET · Market open
Fiscal Quarter
Period Ending
Q2 2020
Jun 30, 2020
Q1 2020
Mar 31, 2020
Q4 2019
Dec 31, 2019
Q3 2019
Sep 30, 2019
Q2 2019
Jun 30, 2019
Q1 2019
Mar 31, 2019
Q4 2018
Dec 31, 2018
Q3 2018
Sep 30, 2018
Q2 2018
Jun 30, 2018
Q1 2018
Mar 31, 2018
Q4 2017
Dec 31, 2017
Q3 2017
Sep 30, 2017
Q2 2017
Jun 30, 2017
Q1 2017
Mar 31, 2017
Q4 2016
Dec 31, 2016
Q3 2016
Sep 30, 2016
Q2 2016
Jun 30, 2016
Q1 2016
Mar 31, 2016
Q4 2015
Dec 31, 2015
Q3 2015
Sep 30, 2015
Q2 2015
Jun 30, 2015
Q1 2015
Mar 31, 2015
PE Ratio
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
PEG Ratio
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
PS Ratio
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
PB Ratio
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
P/FCF Ratio
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
P/OCF Ratio
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
OCF/S Ratio
133.40 40.93 50.45 39.82 37.69 35.62 53.90 41.93 49.60 33.29 29.33 27.88 27.85 28.86 29.08 32.61 24.16 33.16 24.62 34.37 23.72 32.79
Debt / Equity Ratio
0.46 0.48 0.59 0.58 0.59 0.60 0.60 0.61 0.75 0.76 0.78 0.84 0.84 0.83 0.84 0.82 0.82 0.84 0.81 0.86 0.79 0.82
Quick Ratio
0.44 0.60 0.73 1.01 0.98 0.90 0.81 0.72 1.19 0.92 0.81 0.75 0.74 0.64 0.61 0.66 0.62 0.80 0.66 0.82 0.92 0.90
Current Ratio
0.44 0.60 0.73 1.01 0.98 0.90 0.81 0.72 1.19 0.92 0.81 0.75 0.74 0.64 0.61 0.66 0.62 0.80 0.66 0.82 0.92 0.90
Asset Turnover
0.03 0.10 0.10 0.10 0.10 0.10 0.10 0.11 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10
Interest Coverage
n/a n/a -2.19 7.87 7.81 8 6.99 6.40 5.22 5.36 5.13 4.79 4.90 5.09 4.47 4.76 5.02 5.17 5.32 4.81 4.38 4.62
Return on Equity
4.25% 4.97% 3.82% 4.67% 4.71% 4.87% 4.10% 4.61% 4.40% 3.98% 9.06% 3.05% 3.11% 3.19% 2.74% 2.90% 3.27% 3.41% 3.60% 2.98% 2.54% 2.71%
Return on Assets
2.21% 2.54% 1.84% 2.29% 2.30% 2.35% 1.97% 2.23% 2% 1.81% 4.05% 1.27% 1.28% 1.32% 1.13% 1.20% 1.36% 1.40% 1.50% 1.19% 1.06% 1.10%
Return on Invested Capital
2.89% 3.28% 2.47% 2.98% 2.99% 3.04% 2.62% 3.17% 2.73% 2.50% 3.21% 1.83% 1.87% 1.89% 1.68% 1.86% 1.95% 1.98% 2.11% 1.73% 1.57% 1.61%
Dividend Yield
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio
98.84% 99.40% 129.53% 83.86% 73.38% 71.87% 86.42% 77.26% 64.40% 78.95% 23.64% 75.47% 130.60% 89.93% 147.06% 98.04% 138.89% 98.68% 124.61% 242.54% n/a 121.46%
FCF Payout Ratio
103.66% 106.84% 70.32% 72.46% 64.34% 78.83% 43.37% 51.55% 33.37% 71.94% 56.98% 97.56% 160.55% 81.70% 158.37% 60.68% 152.67% 63.03% 219.78% 144.12% n/a 64.24%
Gross Profit Margin
6.49% 75.34% 69.53% 69.10% 71.33% 70.46% 68.72% 67.57% 66.59% 66.81% 67.08% 65.34% 66.10% 66.70% 66.58% 65.99% 67.12% 68.58% 68.59% 67.91% 66.56% 68.79%
Net Profit Margin
82.06% 26.23% 19.18% 23.39% 23.26% 23.70% 19.17% 21.08% 20.32% 17.84% 40.02% 12.38% 12.56% 12.86% 10.78% 11.46% 12.96% 13.49% 14.34% 11.72% 10.71% 11.14%
Pretax Profit Margin
111.26% 35.45% 25.99% 31.54% 31.40% 32.02% 27.31% 26.24% 24.18% 23.94% 22.14% 20.22% 20.53% 20.91% 17.66% 18.60% 21.01% 21.84% 21.89% 19.20% 17.55% 18.67%
Operating Profit Margin
129.58% 40.62% 31.11% 36.68% 36.57% 36.98% 32.42% 33.36% 29.80% 29.67% 28.38% 26.16% 26.86% 26.83% 23.51% 25.88% 27.08% 27.74% 27.79% 25.01% 23.45% 24.58%
FCF Margin
78.24% 24.40% 36.63% 27.07% 26.52% 21.61% 39.33% 31.60% 39.22% 19.58% 17.88% 9.57% 10.22% 14.15% 11.01% 18.51% 11.79% 21.13% 9.07% 19.72% 10.04% 21.06%
EBITDA Margin
173.66% 52.55% 29.03% 53.07% 52.51% 52.99% 48.79% 48.21% 47.07% 46.38% 46.59% 44.23% 44.54% 44.17% 41.94% 43.04% 45.34% 45.63% 47.77% 44.60% 43.56% 44.56%

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.